Daily SPAC Update – March 18, 2025

Hennessey Capital Deal Vote and Metal Sky Star Extension Vote Set. Northview Acquisition Extensino Vote. Quartsea Acquisition $72M IPO.

Boardroom Alpha SPAC Resources
– Full SPAC Listing
– SPAC SEC Filings
– Boardroom Alpha IPO & SPAC Intelligence Platform (7-Day Trial)

Daily SPAC Update

SPAC DEAL & EXTENSION VOTES SET
HCVI – Hennessy Capital Investment Corp Vi * DEAL VOTE SET: Apr 07, 2025 * trust $10.80
MSSA – Metal Sky Star Acquisition Corp * EXTENSION VOTE SET: Apr 02, 2025 * trust $12.35

EXTENSION VOTES
NVAC – NORTHVIEW ACQUISITION CORP * vote March 18, 2025 -> extend to June 22, 2025

NEW SPAC IPOs
Mar 17: QSEA – Quartzsea Acquisition Corp $72M IPO

YESTERDAY’S TOP SPAC GAINERS
6.11% ~ $ 4.17 | BOWN – BOWEN ACQUISITION CORP (Announced)
4.08% ~ $ 12.50 | WINV – WINVEST ACQUISITION CORP (Announced)
1.45% ~ $ 11.22 | ALCY – ALCHEMY INVESTMENTS ACQUISITION CORP 1 (Pre-Deal)
1.10% ~ $ 10.13 | BSII – BLACK SPADE ACQUISITION II CO (Announced)
.90% ~ $ 11.20 | DMYY – DMY SQUARED TECHNOLOGY GROUP INC (Pre-Deal)

YESTERDAY’S TOP SPAC LOSERS
-1.19% ~ $ 11.61 | BNIX – BANNIX ACQUISITION CORP (Pre-Deal)
-.96% ~ $ 11.40 | FTII – FUTURETECH II ACQUISITION CORP (Announced)
-.71% ~ $ 11.26 | FORL – FOUR LEAF ACQUISITION CORP (Announced)
-.61% ~ $ 6.56 | GLST – GLOBAL STAR ACQUISITION INC (Announced)

LATEST SPAC IPO PERFORMANCE
Feb 27 | $ 10.05 | LOKV – Live Oak Acquisition Corp. V
Feb 27 | $ 10.05 | NHIC – NewHold Investment Corp. III
Feb 27 | $ 10.03 | FERA – Fifth Era Acquisition Corp I
Feb 26 | $ 10.02 | RAC – Rithm Acquisition Corp.

Recent Analysis

2026 Proxy Season Scorecard: Six Say-on-Pay Failures, AI Lands on Mega-Cap Ballots, and the Anti-ESG Pile-Up

Through May 21, 2026, U.S. public-company shareholders rejected six annual-meeting Say-on-Pay packages outright, voted against 18 directors at 14 companies, and crushed dozens of mega-cap shareholder proposals at sub-3% support. Plus: AI proposals filed at Alphabet, Meta, Walmart, and IBM; the split verdict on special-meeting rights; the activist-vote scorecard from four 2026 director-slate contests.

Weekly Recap: MO, OHI, WEN Rewire the C-Suite — May 22, 2026

Succession moved from emergency cleanup to portfolio rotation this week, with 24 CEO changes and 21 CFO changes across the tracked C-suite. Altria paired a CEO handoff with a CFO change, Omega Healthcare reset three senior finance and operating seats, and Wendy’s went back to the CEO market for the third time in three years.

Subscribe to Boardroom Alpha Newsletters

Subscribe to Boardroom Alpha's research to receive the latest on governance, SPACs, and people.

Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon. 

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.  

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by BA that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.  

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.